Related Experiment Videos
Platelet-vessel wall interactions: implication of 5-hydroxytryptamine. A review
Agents and Actions
|December 1, 1984
Summary
Platelet-derived serotonin (5-HT) significantly impacts tissue perfusion by activating 5-HT2 receptors. This leads to platelet aggregation and vasoconstriction, impairing blood flow in cardiovascular conditions.
Area of Science:
- Pharmacology
- Vascular Biology
- Cardiovascular Research
Background:
- Platelet-derived 5-hydroxytryptamine (5-HT) plays a role in vascular regulation.
- Serotonin interacts with 5-HT2 receptors on platelets, endothelial cells, and vascular smooth muscle cells.
Purpose of the Study:
- To review the evidence for 5-HT's impact on local tissue perfusion.
- To elucidate the mechanisms by which platelet 5-HT affects vascular function.
Main Methods:
- Review of existing evidence on platelet-derived 5-HT.
- Pharmacological dissection using selective 5-HT2 receptor antagonists (e.g., ketanserin) in experimental animals.
- Analysis of clinical results with ketanserin.
Main Results:
- 5-HT contributes to increased vascular permeability, platelet aggregation, and vasoconstriction.
- Ketanserin administration demonstrated 5-HT's role in hemostasis, cardiopulmonary dysfunction, and inhibited collateral circulation.
- Clinical data support 5-HT's involvement in impaired tissue perfusion in cardiovascular diseases.
Conclusions:
- Platelet-derived 5-HT is a significant factor in regulating local tissue perfusion.
- Targeting 5-HT2 receptors may offer therapeutic potential for cardiovascular conditions involving impaired perfusion.